Featured Research

from universities, journals, and other organizations

Pregnancy, Oral Contraceptives, Hormone Replacement Therapy As Risk Factors For Stroke

Date:
April 16, 1997
Source:
University of Maryland at Baltimore
Summary:
During the weeks immediately following delivery of a baby, new mothers are at increased risk of strokes, a University of Maryland School of Medicine neurology professor told the American Academy of Neurology meeting in Boston this week.

During the weeks immediately following delivery of a baby, new mothersare at increased risk of strokes, a University of Maryland School ofMedicine neurology professor told the American Academy of Neurologymeeting in Boston this week.

Speaking on stroke prevention in the `90s, Dr. Steven Kittner,associate professor of neurology at the medical school in Baltimore,presented data from observational studies indicating a 28-foldincreased risk of intracerebral hemorrhage and a nine-fold increase inrisk of cerebral infarction in women during the six weeks afterdelivery.

Pregnancy itself is associated with no increased risk of cerebralinfarction and only a modestly increased risk of intracerebralhemorrhage, Kittner said.

Oral contraceptives seem to cause a dose-associated increased risk ofstroke, said Kittner. "Current research supports the accepted practiceof restricting the use of oral contraceptives in women who smokecigarettes, have a history of hypertension or other risk factors forvascular disease," he said.

The relationship between postmenopausal estrogen replacement therapyand stroke remains less clear, the neurologist said. One large studyshowed a significantly increased risk of stroke both among womentaking estrogen alone and those taking combination hormone replacementtherapy of estrogen and progestin. But another study showed asignificantly reduced risk of stroke in women taking combinationhormone replacement therapy.

Several large clinical trials now under way should provide moredefinitive data, but for now, "there still are only two wellestablished indications for hormone replacement therapy, relief ofmenopausal symptoms and prevention of osteoporosis," Kittner said. "Many uncertainties persist regarding the risk of combinedestrogen-progestin therapy, and the risks/benefits need to be weighedin each individual case.


Story Source:

The above story is based on materials provided by University of Maryland at Baltimore. Note: Materials may be edited for content and length.


Cite This Page:

University of Maryland at Baltimore. "Pregnancy, Oral Contraceptives, Hormone Replacement Therapy As Risk Factors For Stroke." ScienceDaily. ScienceDaily, 16 April 1997. <www.sciencedaily.com/releases/1997/04/970416205544.htm>.
University of Maryland at Baltimore. (1997, April 16). Pregnancy, Oral Contraceptives, Hormone Replacement Therapy As Risk Factors For Stroke. ScienceDaily. Retrieved July 26, 2014 from www.sciencedaily.com/releases/1997/04/970416205544.htm
University of Maryland at Baltimore. "Pregnancy, Oral Contraceptives, Hormone Replacement Therapy As Risk Factors For Stroke." ScienceDaily. www.sciencedaily.com/releases/1997/04/970416205544.htm (accessed July 26, 2014).

Share This




More Health & Medicine News

Saturday, July 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins